About us Antrad Medical is a Swedish MedTech company founded in 2008. Our vision is to be the preferred partner for RF based thawing and warming. Our mission is to improve management of frozen biological material through RF technology. Antrad proprietary technology ensures even distribution of energy in the entire thawed volume, not just on the surface. Main technology features: Rapid thawing of frozen biological material Controlled adaptive thawing process for preserved quality of sensitive biological material Data from thawing process stored enabling an entirely traceable thawing process of frozen materials Blood Plasma Thawing device UFT100 is based on Antrad technology. This is a CE marked Medical Device Class IIa for simultaneous thawing of two blood plasma bags in just 5-10 minutes. Superior clinical quality has been proven in several studies. Just-in-time plasma thawing improves plasma management and significantly reduces wastage and cost for outdated plasma. Antrad is currently seeking an industrial partner to further develop and commercialize the technology and additional hospital and industrial applications.
About us Antrad Medical is a Swedish MedTech company founded in 2008. Our vision is to be the preferred partner for RF based thawing and warming. Our mission is to improve management of frozen biological material through RF technology. Antrad proprietary technology ensures even distribution of energy in the entire thawed volume, not just on the surface. Main technology features: Rapid thawing of frozen biological material Controlled adaptive thawing process for preserved quality of sensitive biological material Data from thawing process stored enabling an entirely traceable thawing process of frozen materials Blood Plasma Thawing device UFT100 is based on Antrad technology. This is a CE marked Medical Device Class IIa for simultaneous thawing of two blood plasma bags in just 5-10 minutes. Superior clinical quality has been proven in several studies. Just-in-time plasma thawing improves plasma management and significantly reduces wastage and cost for outdated plasma. Antrad is currently seeking an industrial partner to further develop and commercialize the technology and additional hospital and industrial applications.